#
Apo-Tobramycin
  • Treatments
  • Conjunctivitis
  • Bacterial
  • Apo-Tobramycin (Ophthalmic)

Apo-Tobramycin (Ophthalmic)

Generic name: tobramycin (ophthalmic route) [ toe-bra-MYE-sin ]
Drug class:Ophthalmic anti-infectives

Medically reviewed by Drugs.com. Last updated on Jan 22, 2022.

Commonly used brand name(s)

In the U.S.

  • AKTob
  • Tobrasol
  • Tobrex

In Canada

  • Apo-Tobramycin
  • Sab-Tobramycin
  • Tomycine

Available Dosage Forms:

  • Solution
  • Ointment

Therapeutic Class: Antibiotic

Chemical Class: Aminoglycoside

Uses for Apo-Tobramycin

Ophthalmic tobramycin is used in the eye to treat bacterial infections of the eye. Tobramycin works by killing bacteria.

Ophthalmic tobramycin may be used alone or with other medicines for eye infections. Either the drops or the ointment form of this medicine may be used alone during the day. In addition, both forms may be used together, with the drops being used during the day and the ointment at night.

Tobramycin ophthalmic preparations are available only with your doctor's prescription.

Before using Apo-Tobramycin

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

This medicine has been tested in children and, in effective doses, has not been shown to cause different side effects or problems than it does in adults.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of ophthalmic tobramycin in t...